25699-87-0

Basic information

• Product Name: Benzonitrile, 2-(1H-1,2,4-triazol-1-yl)-
• CAS NO: 25699-87-0
• Molecular Formula: C9H6N4
• Molecular Weight: 170.173
• Mol File: 25699-87-0.mol
• Article Data: 10

Chemical Properties

• CAS DataBase Reference: Benzonitrile, 2-(1H-1,2,4-triazol-1-yl)-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzonitrile, 2-(1H-1,2,4-triazol-1-yl)-(25699-87-0)
• EPA Substance Registry System: Benzonitrile, 2-(1H-1,2,4-triazol-1-yl)-(25699-87-0)

Safety Data

• Hazardous Substances Data: 25699-87-0(Hazardous Substances Data)

Upstream product

• 288-88-0 1,2,4-Triazole 
• 394-47-8 2-fluorobenzonitrile 
• 41253-21-8 sodium triazole 

Downstream Products

• 449756-97-2 2-(1,2,4-triazol-1-yl)-benzylamine 
• 724710-05-8 {1-(R)-benzyl-2-oxo-2-[2-(2-[1,2,4]triazol-1-yl-benzyl-carbamoyl)pyrrolidin-1-(S)-yl]-ethyl}carbamic acid tert-butyl ester 
• 138479-54-6 2-(1',2',4'-triazol-1'-yl)benzoic acid 

Relevant articles and documents

2-(1,2,4-triazolyl)benzoyl arylamine active compound for inhibiting pathogens causing take-all disease of wheat

The invention discloses a 2-(1,2,4-triazolyl)benzoyl arylamine active compound for inhibiting pathogens causing the take-all disease of wheat. The active compound is characterized in that the active compound has a structure shown as a formula I which is d

HIV INTEGRASE INHIBITORS

The invention encompasses a series bicyclic pyrimidinone compounds of Formula I which inhibit HIV integrase and prevent viral integration into human DNA. This action makes the compounds useful for treating HIV infection and AIDS. The invention also encompasses pharmaceutical compositions and methods for treating those infected with HIV.

BICYCLIC HETEROCYCLES AS HIV INTEGRASE INHIBITORS

The invention encompasses a series cyclic bicyclic pyrimidinone compounds of Formula I which inhibit HIV integrase and prevent viral integration into human DNA. This action makes the compounds useful for treating HIV infection and AIDS. The invention also encompasses pharmaceutical compositions and methods for treating those infected with HIV.